206 related articles for article (PubMed ID: 30376299)
1. Crystallization Inhibition Properties of Cellulose Esters and Ethers for a Group of Chemically Diverse Drugs: Experimental and Computational Insight.
Mosquera-Giraldo LI; Borca CH; Parker AS; Dong Y; Edgar KJ; Beaudoin SP; Slipchenko LV; Taylor LS
Biomacromolecules; 2018 Dec; 19(12):4593-4606. PubMed ID: 30376299
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic Design of Chemically Diverse Polymers with Applications in Oral Drug Delivery.
Mosquera-Giraldo LI; Borca CH; Meng X; Edgar KJ; Slipchenko LV; Taylor LS
Biomacromolecules; 2016 Nov; 17(11):3659-3671. PubMed ID: 27715018
[TBL] [Abstract][Full Text] [Related]
3. Stabilizing supersaturated drug-delivery system through mechanism of nucleation and crystal growth inhibition of drugs.
Joshi P; Sangamwar AT
Ther Deliv; 2018 Nov; 9(12):873-885. PubMed ID: 30444454
[TBL] [Abstract][Full Text] [Related]
4. Pairwise polymer blends for oral drug delivery.
Marks JA; Wegiel LA; Taylor LS; Edgar KJ
J Pharm Sci; 2014 Sep; 103(9):2871-2883. PubMed ID: 24823790
[TBL] [Abstract][Full Text] [Related]
5. Amorphous solid dispersions of enzalutamide and novel polysaccharide derivatives: investigation of relationships between polymer structure and performance.
Wilson VR; Lou X; Osterling DJ; Stolarik DF; Jenkins GJ; Nichols BLB; Dong Y; Edgar KJ; Zhang GGZ; Taylor LS
Sci Rep; 2020 Oct; 10(1):18535. PubMed ID: 33116200
[TBL] [Abstract][Full Text] [Related]
6. Trends in the precipitation and crystallization behavior of supersaturated aqueous solutions of poorly water-soluble drugs assessed using synchrotron radiation.
Raina SA; Van Eerdenbrugh B; Alonzo DE; Mo H; Zhang GGZ; Gao Y; Taylor LS
J Pharm Sci; 2015 Jun; 104(6):1981-1992. PubMed ID: 25808078
[TBL] [Abstract][Full Text] [Related]
7. Interaction of Polymers with Enzalutamide Nanodroplets-Impact on Droplet Properties and Induction Times.
Wilson VR; Mugheirbi NA; Mosquera-Giraldo LI; Deac A; Moseson DE; Smith DT; Novo DC; Borca CH; Slipchenko LV; Edgar KJ; Taylor LS
Mol Pharm; 2021 Mar; 18(3):836-849. PubMed ID: 33539105
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-property evaluation of cellulose ω-carboxyesters for amorphous solid dispersions.
Liu H; Ilevbare GA; Cherniawski BP; Ritchie ET; Taylor LS; Edgar KJ
Carbohydr Polym; 2014 Jan; 100():116-25. PubMed ID: 24188845
[TBL] [Abstract][Full Text] [Related]
9. Effect of Polymer Hydrophobicity on the Stability of Amorphous Solid Dispersions and Supersaturated Solutions of a Hydrophobic Pharmaceutical.
Frank DS; Matzger AJ
Mol Pharm; 2019 Feb; 16(2):682-688. PubMed ID: 30645134
[TBL] [Abstract][Full Text] [Related]
10. Influence of additives on the properties of nanodroplets formed in highly supersaturated aqueous solutions of ritonavir.
Ilevbare GA; Liu H; Pereira J; Edgar KJ; Taylor LS
Mol Pharm; 2013 Sep; 10(9):3392-403. PubMed ID: 23829687
[TBL] [Abstract][Full Text] [Related]
11. Multidrug, Anti-HIV Amorphous Solid Dispersions: Nature and Mechanisms of Impacts of Drugs on Each Other's Solution Concentrations.
Arca HÇ; Mosquera-Giraldo LI; Dahal D; Taylor LS; Edgar KJ
Mol Pharm; 2017 Nov; 14(11):3617-3627. PubMed ID: 28872867
[TBL] [Abstract][Full Text] [Related]
12. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
Sarode AL; Malekar SA; Cote C; Worthen DR
Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
[TBL] [Abstract][Full Text] [Related]
13. Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.
Verma S; Rudraraju VS
AAPS PharmSciTech; 2015 Oct; 16(5):1079-90. PubMed ID: 25672820
[TBL] [Abstract][Full Text] [Related]
14. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
Xie T; Taylor LS
Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
[TBL] [Abstract][Full Text] [Related]
15. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs.
Sarode AL; Wang P; Obara S; Worthen DR
Eur J Pharm Biopharm; 2014 Apr; 86(3):351-60. PubMed ID: 24161655
[TBL] [Abstract][Full Text] [Related]
16. Conjugation of bile esters to cellulose by olefin cross-metathesis: A strategy for accessing complex polysaccharide structures.
Dong Y; Novo DC; Mosquera-Giraldo LI; Taylor LS; Edgar KJ
Carbohydr Polym; 2019 Oct; 221():37-47. PubMed ID: 31227165
[TBL] [Abstract][Full Text] [Related]
17. Effect of polymers and media type on extending the dissolution of amorphous pioglitazone and inhibiting the recrystallization from a supersaturated state.
Shi NQ; Yao J; Wang XL
Drug Dev Ind Pharm; 2014 Aug; 40(8):1112-22. PubMed ID: 23808528
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of polymer-assisting supersaturation of poorly water-soluble loratadine based on experimental observations and molecular dynamic simulations.
Zhang S; Sun M; Zhao Y; Song X; He Z; Wang J; Sun J
Drug Deliv Transl Res; 2017 Oct; 7(5):738-749. PubMed ID: 28677032
[TBL] [Abstract][Full Text] [Related]
19. Drug-polymer interactions at water-crystal interfaces and implications for crystallization inhibition: molecular dynamics simulations of amphiphilic block copolymer interactions with tolazamide crystals.
Gao Y; Olsen KW
J Pharm Sci; 2015 Jul; 104(7):2132-41. PubMed ID: 26045147
[TBL] [Abstract][Full Text] [Related]
20. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
Widanapathirana L; Tale S; Reineke TM
Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
